bpc-157 clinicaltrials.gov | C62H98N16O22 | CID 9941957 BPC-157 FDA Approval Status 2026:

BPC-157 is a pentadecapeptide consisting of 15 amino acids derived from a biologically active region of a gastric protein sequence, while TB-500 corresponds to a synthetic fragment of thymosin beta-4 that retains actin-binding regulatory activity observed in the native protein

They name it as this anti stress compound is how they, they, they look at it now when they do that Achilles paper on the mice, that's what explodes the bodybuilder interest and leads us to today where we are like, oh, MSK injuries must be bpc tendons and muscle injuries

Format & Handling This compound is supplied in a sterile laboratory glass vial containing 50mg of lyophilized research material

- Lithium: because it reduces the renal clearance and increases lithium levels in plasma which increases the risk of lithium toxicity

I feel like they make really solid recommendations and everybody is super friendly

It mimics a fragment of the native gastric protein, which may allow it to interact with receptors involved in tissue repair without provoking a strong immune response